COMMUNIQUÉS West-GlobeNewswire

Kiadis Pharma N.V notice of Annual General Meeting of shareholders
23/04/2018
Amsterdam, The Netherlands, April 23, 2017 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS ), a clinical stage biopharmaceutical company developing a T-cell immunotherapy [...]
Curetis to Publish its 2017 Annual Results on April 30, 2018
23/04/2018
Curetis to Publish its 2017 Annual Results on April 30, 2018 - Company to host earnings conference call and webcast Amsterdam, the Netherlands, San Diego, CA, USA and Holzgerlingen, Germany, April 23, 2017, 01:00 am EDT [...]
Akcea Therapeutics to Present Data on Inotersen for the Treatment of hATTR Amyloidosis at the 2018 American Academy of Neurology Annual Meeting
21/04/2018
Two oral presentations further demonstrate inotersen’s impact on efficacy and safety and on patient quality of life CAMBRIDGE, Mass., April 21, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (Nasdaq: AKCA ), an [...]
Accelerate Diagnostics announces sizeable release of new data at ECCMID 2018
21/04/2018
Four integrated symposium sessions, 11 poster presentations, and case studies will cover the clinical value of integrating diagnostic stewardship into current sepsis protocols given the rising rates of antibiotic [...]
Caelum Biosciences Submits Draft Registration Statement on Form S-1 to the Securities and Exchange Commission
21/04/2018
NEW YORK, April 20, 2018 (GLOBE NEWSWIRE) -- Caelum Biosciences, Inc. (“Caelum”), a Fortress Biotech, Inc. Company developing treatments for rare and life-threatening diseases, today announced it has confidentially [...]
Pacific Biosciences of California, Inc. First Quarter 2018 Financial Results Call
21/04/2018
MENLO PARK, Calif., April 20, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB ) will hold its quarterly conference call to discuss its First Quarter 2018 Financial Results on Wednesday, [...]
Orion to sell its Orion Diagnostica division - Due to the transaction Orion updates its outlook
21/04/2018
ORION CORPORATION STOCK EXCHANGE RELEASE 21 APRIL 2018 at 01.30 a.m. EEST Orion to sell its Orion Diagnostica division - Due to the transaction Orion updates its outlook Orion Corporation ("Orion") announced on 23 [...]
Bellicum Pharmaceuticals Announces Closing of Public Offering
20/04/2018
HOUSTON, April 20, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM ) a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan [...]
Kalytera Announces Next Payment in Shares under Services Agreement with Salzman Group
20/04/2018
SAN FRANCISCO and TEL AVIV, Israel, April 20, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the " Company " or " Kalytera ") today announced that the Company has elected to issue [...]
Marrone Bio Innovations Announces Closing of $12 Million Public Offering of Common Stock
20/04/2018
DAVIS, Calif., April 20, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI or the “Company”), a leading provider of bio-based pest management and plant health products for the agriculture, turf [...]
Shire plc : Statement re Proposal from Takeda Pharmaceutical Company Limited
20/04/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT [...]
Sienna Announces 2018 Annual and Special Meeting
20/04/2018
MARKHAM, Ontario, April 20, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (" Sienna " or the " Company ") (TSX: SIA ) today announced that it will be hosting its 2018 annual and special meeting of shareholders on [...]
IBA SA : data concerning transparency
20/04/2018
IBA - DATA CONCERNING TRANSPARENCY Heading II of the law of May 2, 2007 and the Royal Decree of February 14, 2008 Louvain-la-Neuve, Belgium, April 20, 2018 - IBA (Ion Beam Applications SA), the world's leading provider [...]
IBA SA : Information en matière de transparence
20/04/2018
IBA - INFORMATIONS EN MATIERE DE TRANSPARENCE Titre II de la loi du 2 mai 2007 et Arrêté Royal du 14 février 2008 Louvain-la-Neuve, Belgique, 20 avril 2018 - IBA (Ion Beam Applications SA), le premier fournisseur [...]
LifePoint Health To Broadcast Its First Quarter 2018 Conference Call Live On The Internet
20/04/2018
Brentwood, Tenn., April 20, 2018 (GLOBE NEWSWIRE) -- LifePoint Health, Inc. (NASDAQ: LPNT) announced today that it will provide an online Web simulcast of its first quarter 2018 conference call on Friday, May 4, 2018. [...]
Trinity Biotech plc to Announce First Quarter Fiscal Year 2018 Financial Results
20/04/2018
Conference Call Scheduled for May 1, 2018 at 11:00 am EASTERN DUBLIN, April 20, 2018 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB ), a leading developer and manufacturer of diagnostic products for the point-of- [...]
Hemispherx Announces Pricing of $2.57 Million Registered Direct Offering at a Premium to Market
20/04/2018
ORLANDO, Fla., April 20, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB) (“Hemispherx” or the “Company”), a research and development and emerging commercial growth company focused on unmet [...]
Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO® (fosnetupitant/ palonosetron) in the United States
20/04/2018
Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO ® (fosnetupitant/ palonosetron) in the United States Lugano, Switzerland April 20, 2018 - Helsinn, a Swiss pharmaceutical group focused on [...]
Ceapro Inc. Reports 2017 Financial Results
20/04/2018
Year marked by increased investments in product pipeline and enabling technologies EDMONTON, Alberta, April 20, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO ) (“Ceapro” or the “Company”) , a growth-stage [...]

Pages